Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sarah Kelddal"'
Publikováno v:
BMC Nephrology, Vol 23, Iss 1, Pp 1-8 (2022)
Abstract Background Nephrotic syndrome (NS) is associated with increased risk of thromboembolic events (TE) adding to the morbidity and mortality. International guidelines recommend prophylactic anticoagulation in patients with NS and high risk of TE
Externí odkaz:
https://doaj.org/article/5fbbe110080441039781280a5c497c06
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-6 (2019)
Abstract Background An increased incidence of thromboembolic events (TE) are reported in nephrotic syndrome (NS) leading to recommendations for prophylactic anticoagulation (PAC). However, as no randomized clinical trial has established the efficacy
Externí odkaz:
https://doaj.org/article/580d645001d84888b6f1a279ad1a72a7
Publikováno v:
Kelddal, S, Hvas, A-M, Grove, E L & Birn, H 2022, ' Safety and effectiveness of direct oral anticoagulants in patients with nephrotic syndrome : a report of 21 cases ', BMC Nephrology, vol. 23, 305 . https://doi.org/10.1186/s12882-022-02929-x
Background Nephrotic syndrome (NS) is associated with increased risk of thromboembolic events (TE) adding to the morbidity and mortality. International guidelines recommend prophylactic anticoagulation in patients with NS and high risk of TE, but no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d337f231c534ee4f59a73f4b174d865
https://pure.au.dk/portal/da/publications/safety-and-effectiveness-of-direct-oral-anticoagulants-in-patients-with-nephrotic-syndrome(677fb9f4-b88c-4950-83a2-0d62e3301d30).html
https://pure.au.dk/portal/da/publications/safety-and-effectiveness-of-direct-oral-anticoagulants-in-patients-with-nephrotic-syndrome(677fb9f4-b88c-4950-83a2-0d62e3301d30).html
Publikováno v:
BMC Nephrology
Kelddal, S, Nykjær, K M, Gregersen, J W & Birn, H 2019, ' Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications ', BMC Nephrology, vol. 20, no. 1, 139, pp. 1-6 . https://doi.org/10.1186/s12882-019-1336-8
Kelddal, S, Nykjær, K M, Gregersen, J W & Birn, H 2019, ' Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications ', BMC Nephrology, vol. 20, no. 1, 139 . https://doi.org/10.1186/s12882-019-1336-8
BMC Nephrology, Vol 20, Iss 1, Pp 1-6 (2019)
Kelddal, S, Nykjær, K M, Gregersen, J W & Birn, H 2019, ' Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications ', BMC Nephrology, vol. 20, no. 1, pp. 139 . https://doi.org/10.1186/s12882-019-1336-8
Kelddal, S, Nykjær, K M, Gregersen, J W & Birn, H 2019, ' Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications ', BMC Nephrology, vol. 20, no. 1, 139, pp. 1-6 . https://doi.org/10.1186/s12882-019-1336-8
Kelddal, S, Nykjær, K M, Gregersen, J W & Birn, H 2019, ' Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications ', BMC Nephrology, vol. 20, no. 1, 139 . https://doi.org/10.1186/s12882-019-1336-8
BMC Nephrology, Vol 20, Iss 1, Pp 1-6 (2019)
Kelddal, S, Nykjær, K M, Gregersen, J W & Birn, H 2019, ' Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications ', BMC Nephrology, vol. 20, no. 1, pp. 139 . https://doi.org/10.1186/s12882-019-1336-8
BACKGROUND: An increased incidence of thromboembolic events (TE) are reported in nephrotic syndrome (NS) leading to recommendations for prophylactic anticoagulation (PAC). However, as no randomized clinical trial has established the efficacy or risks
Publikováno v:
Nephrology Dialysis Transplantation. 33:i95-i95